Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Licensed from American College of Cardiology
Insights From the REDUCE-AMI TrialIn this patient population, beta-blocker use did not result in lower incidence of composite death from any cause or new myocardial infarction.
The Global Applicability of the DanGer Shock TrialPositive results were shown for implantation of a mechanical circulatory support device plus standard care for patients presenting with cardiogenic shock and STEMI.
